Loading fund overlap…
17 of 54 unique stocks in common · Jaccard: 31.5%
A weighted portfolio overlap of 21.14% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹21.14 is allocated to the exact same companies at the same relative proportions. The schemes share 17 common holdings.
The largest overlapping asset in their portfolios is Infosys, which commands a weight of 18.93% in Nippon India ETF Nifty 50 Shariah BeES and 3.76% in SBI Nifty 50 ETF. Holding both schemes increases your concentration in Infosys rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in Nippon | in SBI |
|---|---|---|
| InfosysIT - Software | 18.93% | 3.76% |
| Tata Consultancy ServicesIT - Software | 14.45% | 2.13% |
| Hindustan UnileverDiversified FMCG | 7.44% | 1.77% |
| Tata SteelFerrous Metals | 5.08% | 1.59% |
| Ultratech CementCement & Cement Products | 4.30% | 1.26% |
| HCL TechnologiesIT - Software | 5.40% | 1.15% |
| Asian PaintsConsumer Durables | 4.84% | 1.12% |
| Grasim IndustriesCement & Cement Products | 3.32% | 1.10% |
| Coal IndiaConsumable Fuels | 3.87% | 0.96% |
| Oil & Natural Gas CorporationOil | 4.12% | 0.95% |
| Nestle IndiaFood Products | 3.34% | 0.94% |
| Tech MahindraIT - Software | 2.99% | 0.87% |
| Adani EnterprisesMetals & Minerals Trading | 2.99% | 0.78% |
| Apollo Hospitals EnterpriseHealthcare Services | 2.23% | 0.78% |
| CiplaPharmaceuticals & Biotechnology | 2.74% | 0.73% |
| Tata Consumer ProductsAgricultural Food & Other Products | 2.60% | 0.71% |
| WiproIT - Software | 2.44% | 0.54% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.